Clear, greaseless skin-care compositions

ABSTRACT

The present invention relates to compositions including anhydrous compositions which include dimethicone crosspolymer and/or dimethicone elastomer gum and one or more skin care products which may include retinoic acid, retinoic acid derivatives, retinal, retinol and/or retinyl esters.

RELATED APPLICATION

This is a continuation-in-part of co-pending U.S. patent applicationSer. No. 10/254,418, filed Sep. 25, 2002, the disclosure of which ishereby incorporated herein in its entirety by reference.

FIELD OF THE INVENTION

The present invention relates to clear, greaseless compositions whichinclude a pharmaceutically active component. The compositions arepreferably anhydrous and include silicones, for example, one or more ofdimethicone crosspolymers, dimethicone gum, hexamethyldisiloxane and lowmolecular weight dimethicones.

More particularly, the composition may be a topically appliedcomposition containing one or more analgesics or one or more skin carecomponents.

In a further and more specific aspect, the invention relates to clear,greaseless compositions including a pharmaceutically active componentsuch as an analgesic including methyl salicylate, camphor, menthol andcapsaicin or a skin care component selected from the group consisting ofanti-wrinkle components, anti-skin atrophy components, skin repaircomponents, and mixtures thereof. Advantageously, the pharmaceuticallyactive component is a skin care component selected from the groupconsisting of retinoic acid, retinoic acid derivatives, retinal,retinol, retinyl esters and mixtures thereof.

BACKGROUND

Various pharmaceutical products are designed for topical application,for instance in the form of gels, creams and lotions. Among suchproducts are compositions including anti-acne actives, antimicrobial andantifungal actives, anti-wrinkle and anti-skin atrophy actives, skinbarrier repair aids, cosmetic soothing aids, artificial tanning agentsand accelerators, skin lightening actives, sunscreen actives, skintightening agents, anti-itch agents, hair growth inhibitors,desquamating agents, anti-glycation agents, wound healing actives,actives to treat psoriasis, skin cancer, impetigo, herpes, chickenpoxand dermatitis and mixtures thereof.

Some of the above compositions include components that are insoluble oronly slightly soluble in water, but are readily soluble in non-polarsubstances such as organic solvents and oils. However, compositionsincluding oils and the like have certain drawbacks in their use. Forexample, they may produce a sticky and/or greasy feel upon applicationto the skin. The compositions may also be inconvenient for use by, forexample, requiring an extended drying time after application to the skinand/or staining the skin and/or clothing. In addition, thesecompositions do not necessarily provide for a film layer that will beeffective to retain volatile actives. Further, after application thecompositions typically are easily solubilized by aqueous solutions suchas perspiration which may lead to loss of the composition and/or theactives. Further, water or oil containing compositions often includeemulsifiers which can cause skin irritation. In addition, the process ofmaking these compositions typically involves heating which may lead tothe loss of the actives by, for example, evaporation and/or sublimation.

Two classes of pharmaceutical compositions particularly prone to theaforementioned drawbacks are skin-care compositions and analgesics.

Of special interest in the category of skin care compositions arecompositions including anti-wrinkle components, anti-skin atrophycomponents, skin repair components and mixtures thereof, andparticularly skin care compositions selected from the group consistingof retinoic acid, retinoic acid derivatives, retinal, retinol, retinylesters and mixtures thereof.

Retinol, perhaps the most well known of these compositions, isfrequently used in anti-aging creams, lotions, and serums. Becauseretinol is very unstable to heat, light, and oxygen, products containingretinol currently must be manufactured under inert gas conditions andpackaged in aluminum tubes to prevent oxygen or light from degrading theactive retinol. These restrictive manufacturing and packaging conditionsincrease the overall cost of the skin-care products, making themunaffordable to many consumers.

Also of interest are analgesic compositions, particularly compositionsselected from the group consisting of methyl salicylate, camphor,menthol and capsaicin. Methyl salicylate is a 2-hydroxybenzoic acidmethyl ester which can occur naturally in wintergreen oil, betula oil,sweet birch oil, teaberry oil and in the leaves of Gualtheria procumbensL. Ericadeae and in the bark of Betula lenta L. Betulaceae. It can alsobe prepared by etherification of salicylic acid with methanol. Camphoris 1,7,7-trimethylbicyclo[2,2,1]heptan-2-one and occurs in all parts ofthe camphor tree, Cinnamomum camphora T. It is also synthesized fromvinyl chloride and cyclopentadiene. Menthol, or5-methyl-2-[1-methylethyl]-cyclohexanol, can be obtained from mint oils,for example, peppermint oil. It can also be obtained throughhydrogenation of thymol. Capsaicin, orN-(4-hydroxy-3-methoxybenzyl)-8-methylnontrans-6-enamide, can beobtained from the fruits of plants of the Capsicum genus.

Water and oil containing compositions such as gels, lotions and creamsare useful for application of menthol, camphor, and capsaicin and methylsalicylate as well as other analgesics. U.S. Pat. No. 5,124,320 and U.S.Pat. No. 5,013,726 disclose compositions in which methyl salicylate,menthol and camphor are dissolved into C12-C15 alcohols benzoate,eucalyptus oil and jojoba oil.

There remains a need for topically applied compositions which may beused to apply skin-care products and/or analgesics which are easily andeconomically prepared, are non-sticky, greaseless, require less dryingtime after application to the skin, do not stain the skin, provide waterresistance or waterproofing, act to efficiently retain actives and arenot irritating to the skin.

In addition, a need exists for skin-care products, particularlyretinol-containing skin-care products, which can be economicallypackaged in opaque containers and which remain stable when exposed tooxygen and/or higher than normal temperatures.

SUMMARY

The present invention meets these needs. Compositions of the inventioncan be manufactured at relatively low cost under non-restrictiveconditions. Such compositions are preferably anhydrous with no oilycomponent, and as such have a reduced greasy feel relative to similar oridentical compositions which include oil and/or water. Advantageously,the compositions will dry in a reduced period of time relative tosimilar or identical compositions which include oil and/or water. Inaddition, the compositions may be made at room temperature whichdecreases the loss of certain actives during production. Moreover, theapplied composition has increased resistance to being washed off orrubbed off, and has greater adhesion to the skin relative to aqueous oroil based compositions. Further, these compositions can provide a waterresistant or water proof film when applied to a surface, for example,when applied to the skin. This water resistance or water proofing canprevent an undesired removal of actives upon exposure to moisturethereby retaining the active component in proximity to the surface (e.g.skin) to which the composition is applied. The water resistance or waterproofing may be provided, at least in part, by a silicone component,which may include dimethicone gum and/or dimethicone crosspolymer,included in a composition.

In one broad embodiment, the present invention provides for an effectiveamount of a pharmaceutically active component to be included in asilicone component which may include a low molecular weight silicone(e.g., hexamethyldisiloxane and/or low molecular weight dimethicone) anda high molecular weight silicone (e.g., dimethicone crosspolymer and/ordimethicone elastomer gum). The high molecular weight silicone may bepresent in an amount effective to produce a composition with a desiredconsistency.

In one embodiment, the present invention provides for an anhydrouscomposition which includes a dimethicone crosspolymer and/or adimethicone gum and an analgesic component. The dimethicone crosspolymermay have a molecular weight of between about 100,000 and about100,000,000. The dimethicone gum may have a molecular weight of betweenabout 100,000 and about 100,000,000. In still another embodiment, acomposition includes the dimethicone crosspolymer and the dimethiconegum. In one embodiment, the dimethicone crosspolymer and/or dimethiconegum comprises about 10% to about 99.999% by weight of the composition.

In a particularly useful embodiment, the compositions include a lowmolecular weight silicone. Examples of low molecular weight siliconesthat may be included in a composition include, without limitation, lowmolecular weight dimethicone, cyclic silicones, andhexamethyldisiloxane.

The compositions may include a skin-care component selected from thegroup consisting of anti-wrinkle components, anti-skin atrophycomponents, skin repair components, and mixtures thereof. The skin carecomponent is advantageously selected from the group consisting ofretinoic acid, retinoic acid derivatives, retinal, retinol, retinylesters and mixtures thereof. The skin care component may comprise about0.0001% to about 1% or about 5% or about 10% by weight of thecomposition. In a particularly useful embodiment, the skin carecomponent comprises about 0.0001% or about 0.01% or about 0.1% to about0.3% to about 0.4% or 0.5% or about 1%, by weight of the composition.

Alternatively, the compositions may include an analgesic component whichincludes one or more analgesics. Examples of analgesics which may beincluded in the present compositions include camphor, menthol, capsaicinand methyl salicylate and mixtures thereof. The analgesic may compriseabout 0.001% to about 90% of the composition by weight.

Each and every feature described herein, and each and every combinationof two or more of such features, is included within the scope of thepresent invention provided that the features included in such acombination are not mutually inconsistent.

These and other aspects and advantages of the present invention areapparent in the following detailed description, examples and claims.

DETAILED DESCRIPTION

The present invention is based in part upon the discovery of clear,greaseless silicone-containing compositions which may be anhydrous andinclude a pharmaceutically active component. The present invention alsoincludes methods of making and using such compositions.

In one embodiment, the invention relates to compositions which includeone or more of dimethicone crosspolymers, dimethicone gum,hexamethyldisiloxane and low molecular weight dimethicones. The activecomponent may include one or more analgesics to treat pain. Particularlyuseful analgesics which may be included in a composition include,without limitation, methyl salicylate, camphor, menthol and capsaicin.

Particularly useful embodiments of the present composition include oneor more of methyl salicylate menthol, camphor and capsaicin. In oneembodiment, the active component includes methyl salicylate, menthol,camphor and capsaicin. In another embodiment, the active componentincludes menthol, camphor and capsaicin. In another embodiment, theactive component includes camphor and capsaicin. In another embodiment,the active component includes capsaicin. In another embodiment, theactive component includes camphor. In another embodiment, the activecomponent includes menthol. In another embodiment, the active componentincludes methyl salicylate. In another embodiment, the active componentincludes methyl salicylate and camphor. In another embodiment, theactive component includes methyl salicylate and menthol. In anotherembodiment, the active component includes methyl salicylate, camphor andcapsaicin. In another embodiment, the active component includes methylsalicylate and capsaicin. In another embodiment, the active componentincludes menthol, and capsaicin. In another embodiment, the activecomponent includes methyl salicylate, menthol and capsaicin. In anotherembodiment, the active component includes methyl salicylate menthol andcamphor.

These and other embodiments of the present invention are effective toprovide relief from pain by topical application to an animal patient,for example, topical application to a human patient, for example,application to the skin of a human patient. Without wishing to limit theinvention to any theory or mechanism of operation, it is believed thatthese analgesics can relieve pain in areas of a body including, but notlimited to, the skin, muscles, joints, or viscera distal to the site ofapplication by stimulating depressing cutaneous sensory receptors.

Additional analgesics which may be included in a composition include,without limitation, salicylic acid, salicylic acid derivatives such astriethanolamine salicylate, histamine dihydrochloride, methyl nicotinateand wintergreen, eucalyptus and turpentine extracts as well as othercounter irritants.

The active component may also include topical anesthetics such aspharmaceutically-acceptable salts of lidocaine, bupivacaine,chlorprocaine, dibucaine, etidocaine, mepivacaine, tetracaine,dyclonine, hexylcaine, procaine, cocaine, ketamine, pramoxine andphenol. Also included for use in the present compositions may beantipruritic drugs which include, without limitation,pharmaceutically-acceptable salts of methdilizine and trimeprazine.

Also included in an active component may be non-steroidalanti-inflammatory drugs (NSAIDS). The NSAIDS can be selected from thefollowing categories: propionic acid derivatives; acetic acidderivatives; fenamic acid derivatives; biphenylcarboxylic, acidderivatives; and oxicams. All of these NSAIDS are described in the U.S.Pat. No. 4,985,459, which is incorporated in its entirety by referenceherein. Propionic NSAIDS including but not limited to aspirin,acetaminophen, ibuprofen, naproxen, benoxaprofen, flurbiprofen,fenoprofen, fenbufen, ketoprofen, indoprofen, pirprofen, carprofen,oxaprozin, pranoprofen, miroprofen, tioxaprofen, suprofen, alminoprofen,tiaprofenic acid, fluprofen and bucloxic acid. Also useful are thesteroidal anti-inflammatory drugs including hydrocortisone and the like.

Active ingredients useful herein may be categorized by their therapeuticbenefit or their postulated mode of action such as analgesics, forexample, topical analgesics. However, it is to be understood that theactive ingredients useful herein can in some instances provide more thanone therapeutic benefit or operate via more than one mode of action.Therefore, classifications herein are made for the sake of convenienceand are not intended to limit the active ingredient to that particularapplication or applications listed. Furthermore,pharmaceutically-acceptable salts of these active ingredients are alsouseful in accordance with the invention.

Other classes of active ingredients contemplated for use in the presentcompositions include anti-acne actives, antimicrobial and antifungalactives, anti-wrinkle and anti-skin atrophy actives, skin barrier repairaids, cosmetic soothing aids, artificial tanning agents andaccelerators, skin lightening actives, sunscreen actives, skintightening agents, anti-itch agents, Hair growth inhibitors,desquamating agents, anti-glycation agents, wound healing actives,actives to treat psoriasis, skin cancer, impetigo, herpes, chickenpoxand dermatitis and mixtures thereof.

Anti-Acne Actives:

Nonlimiting examples of useful anti-acne actives include thekeratolytics such as salicylic acid (o-hydroxybenzoic acid), derivativesof salicylic acid such as 5-octanoyl salicylic acid and 4methoxysalicylic acid, and resorcinol; retinoids such as retinoic acidand its derivatives (e.g., cis and trans); sulfur-containing D and Lamino acids and their derivatives and salts, particularly their N-acetylderivatives, for example, N-acetyl-L-cysteine; lipoic acid; antibioticsand antimicrobials such as benzoyl peroxide, octopirox, tetracycline,2,4,4′-trichloro-2′-hydroxy diphenyl ether, 3,4,4′-trichlorobanilide,azelaic acid and its derivatives, phenoxyethanol, phenoxypropanol,phenoxyisopropanol, ethyl acetate, clindamycin and meclocycline;sebostats such as flavonoids and bioflavonoids; bile salts such asscymnol sulfate and its derivatives, deoxycholate, and cholate; abieticacid; adapalene; allantoin; aloe extracts; arbietic acid and its salts;aryl-2,4 dioxo oxazolidine derivatives; ASEBIOL (available fromLaboratories Serobiologiques, located in Somerville, N.J.); azaleicacid; barberry extracts; bearberry extracts; belamcanda chinensis;benzoquinolinones; benzoyl peroxide; berberine; BIODERMINE (availablefrom Sederma, located in Brooklyn, N.Y.); bioflavinoids; bisabolol;S-carboxymethyl cysteine; carrot extracts; cassin oil; clove extracts;citral; citronellal; climazole; Completech MBAC-OS (available fromLipo); CREMOGEN M82 (available from Dragoco, located in Totowa, N.J.);cucumber extracts; dehydroacetic acid and its salts;dehydroeplandersterone salicylate; dichlorophenyl imidazoldioxolan whichis commercially available as COMPLETECH MBAC-OS (from Lipo, located inPaterson, N.J.); DL valine and its esters; DMDM hydantoin; Epicutin TT(available from CLR); erythromycin; escinol; ethyl hexyl monoglycerylether; ethyl 2-hydroxy undecanoate; farnesol; farnesol acetate;geranoil; glabridin; gluconic acid; gluconolactone; glycerylmonocaprate; glycolic acid; grapefruit seed extract; gugu lipid;Hederagenin (available from Maruzen); hesperitin; hinokitol; hopsextract; hydrogenated rosin; 10 hydroxy decanoic acid; ichtyhol;interleukin 1 alpha antagonists; iodo-2-propynyl butyl carbamate;Kapilarine (available from Greentech); ketoconazole; lactic acid; lemongrass oil; Lichochalcone LR15 (available from Maruzen); linoleic acid;LIPACIDE C8CO (available from Seppic, located in Paris, France);lovastatin; 4 methoxysalicylic acid; metronidazole; minocycline;mukurossi; neem seed oil; vitamin B3 compounds (such as niacinamide andnicotinic acid); nisin; 5-octanoly salicylic acid; octopirox; panthenol;1-pentadecanol; peonia extract; peppermint extract; phelladendronextract; 2-phenyl-benzothiophene derivatives; phloretin; PHLOROGINE(available from Secma); phosphatidyl choline; proteolytic enzymes;quercetin; red sandalwood extract; resorcinol; rosemary extract; rutin;sage extract; salicin; salicylic acid; skull cap extract; siber hegnerextract; siberian saxifrage extract; silicol; sodium lauryl sulfate;sodium sulfoacetamide; Sophora Extract (available from Maruzen); sorbicacid; sulfur; sunder vati extract; tea tree oil; tetracyline; tetrahydroabietic acid; thyme extract; tioxolone; tocopherol; trehalose6-undecylenoate; 3 tridecene-2-ol; triclosan; tropolone; UNITRIENOL T27(available from Unichem, located in Gouda, Netherlands); vitamin D₃ andits analogs; white thyme oil; willow bark extract; wogonin; Ylang Ylang;zinc glycerolate; zinc linoleate; zinc oxide; zinc pyrithione; zincsulfate and mixtures thereof.

Antimicrobial and Antifungal Actives:

Antimicrobial and antifungal actives can be effective to prevent theproliferation and growth of bacteria and fungi. Nonlimiting examples ofantimicrobial and antifungal actives include β-lactam drugs, quinolonedrugs, ciprofloxacin, norfloxacin, tetracycline, erythromycin, amikacin,2,4,4′-trichloro-2′-hydroxy diphenyl ether, 3,4,4′-trichlorobanilide,phenoxyethanol, phenoxy propanol, phenoxyisopropanol, doxycycline,capreomycin, chlorhexidine, chlortetracycline, oxytetracycline,clindamycin, ethambutol, hexamidine isethionate, metronidazole,pentarnidine, gentamicin, kanamycin, lineomycin, methacycline,methenamine, minocycline, neomycin, netilmicin, paromomycin,streptomycin, tobramycin, miconazole, tetracycline hydrochloride,erythromycin, zinc erythromycin, erythromycin estolate, erythromycinstearate, amikacin sulfate, doxycycline hydrochloride, capreomycinsulfate, chlorhexidine gluconate, chlorhexidine hydrochloride,chlortetracycline hydrochloride, oxytetracycline hydrochloride,clindamycin hydrochloride, ethambutol hydrochloride, metronidazolehydrochloride, pentamidine hydrochloride, gentamicin sulfate, kanamycinsulfate, lineomycin hydrochloride, methacycline hydrochloride,methenamine hippurate, methenamine mandelate, minocycline hydrochloride,neomycin sulfate, netilmicin sulfate, paromomycin sulfate, streptomycinsulfate, tobramycin sulfate, miconazole hydrochloride, amanfadinehydrochloride, amanfadine sulfate, octopirox, parachlorometa xylenol,nystatin, tolnaftate, zinc pyrithione; clotrimazole; alantolactone;isoalantolactone; alkanet extract (alaninin); anise; arnica extract(helenalin acetate and 11,13 dihydrohelenalin); Aspidium extract(phloro, lucinol containing extract); barberry extract (berberinechloride); bay sweet extract; bayberry bark extract (myricitrin);benzalkonium chloride; benzethonium chloride; benzoic acid and itssalts; benzoin; benzyl alcohol; blessed thistle; bletilla tuber;bloodroot; bois de rose oil; burdock; butyl paraben; cade oil; CAE(available from Ajinomoto, located in Teaneck, N.J.); cajeput oil;Cangzhu; capsicum frutescens extract; caraway oil; cascarilla bark (soldunder the tradename ESSENTIAL OIL); cedarleaf oil; chamomille;chaparral; chlorhexidine gluconate; chlorophenesin; chlorxylenol;cinnamon oil; citronella oil; clove oil; Crinipan AD (available fromClimbazole); 2,3-dihydro-farnesol; dehydroacetic acid and its salts;dill seed oil; DOWICIL 200 (available from Dow Chemical, located inMidland, Mich.); echinacea; elenolic acid; epimedium; ethyl paraben;Fo—Ti; galbanum; garden bumet; GERMALL 115 and GERMALL II (availablefrom ISP-Sutton Labs, located in Wayne, N.J.); German chamomille oil;giant knotweed; GLYDANT (available from Lonza, located in Fairlawn,N.J.); GLYDANT PLUS (available from Lonza); grapefruit seed oil; 1,6hexanediol; hexamidine diisethionate; hinokitiol; honey; honeysuckleflower; hops; immortelle; iodopropynl butyl carbamide (available fromLonza); isobutyl paraben; isopropyl paraben; JM ACTICARE (available fromMicrobial Systems International, located in Nottingham, NG); juniperberries; KATHON CG (available from Rohm and Haas, located inPhiladelphia, Pa.); kojic acid; labdanum; lavender; lemon balm oil;lemon grass; methyl paraben; mint; mume; mustard; myrrh; neem seed oil;ortho phenyl phenol; olive leaf extract (available from Bio Botanica);parsley; patchouly oil; peony root; 1,2 pentandiol; PHENONIP (availablefrom Nipa Labs, located in Wilmington, Del.); phenoxyethanol;phytosphingosine; pine needle oil; PLANSERVATIVE (available from CampoResearch); propyl paraben; purslane; quillaira; rhubarb; rose geraniumoil; rosemary; sage; salicylic acid; sassafras; savory; sichuan lovage;sodium meta bisulfite; sodium sulfite; SOPHOLIANCE (available fromSoliance, located in Compiegne, France); sorbic acid and its salts;sphingosine; stevia; storax; sucrose esters; tarmic acid; tea; tea treeoil (cajeput oil); thyme; triclosan; triclocarban; tropolone;turpentine; umbelliferone (antifungal); yucca; and mixtures thereof.

Anti-Wrinkle, Anti-Skin Atrophy and Skin Repair Actives:

Anti-wrinkle, anti-skin atrophy and skin repair actives can be effectivein replenishing or rejuvenating the epidermal layer. These activesgenerally provide these desirable skin care benefits by promoting ormaintaining the natural process of desquamation. Nonlimiting examples ofantiwrinkle and anti-skin atrophy actives include retinoic acid and itsderivatives (e.g., cis and trans); retinal; retinol; retinyl esters suchas retinyl acetate, retinyl palmitate, and retinyl propionate; vitamin Bcompounds (such as niacinamide and nicotinic acid), salicylic acid andderivatives thereof (such as 5-octanoyl salicylic acid, heptyloxy 4salicylic acid, and 4-methoxy salicylic acid); sulfur-containing D and Lamino acids and their derivatives and salts, particularly the N-acetylderivatives, for example, N-acetyl-L-cysteine; thiols, e.g. ethanethiol; hydroxy acids, phytic acid, lipoic acid; lysophosphatidic acid;skin peel agents (e.g., phenol and the like); Actein 27-DeoxyacteinCimicifugoside (available from Cirnigoside); adapalene; ademethionine;adenosine; aletris extract; alkyl glutathione esters; alkoxyalkoxyalkoxyn benzoic and derivatives; aloe derived lectins; amino propanephosphoric acid; 3-aminopropyl dihydrogen phosphate; Amadorine(available from Barnet Products); anise extracts; AOSINE (available fromSecma); arginine amino benzoate; ASC III (available from E. Merck,located in Darmstadt, Germany); ascorbic acid; ascorbyl palmitate;asiatic acid; asiaticosides; ARLAMOL GEO™ (available from IC, located inWilmington, Del.); azaleic acid; benzoic acid derivatives; Bertholletiaextracts; betulinic acid; BIOCHANIN A AND BIOPEPTIDE CL (available fromSederma, located in Brooklyn, N.Y.); BIOPEPTIDE EL (available fromSederma); biotin; blackberry bark extract; blackberry lily extracts;black cohosh extract; blue cohesh extract; butanoyl betulinic acid;carboxymethyl 1,3 beta glucan; catecholamnines; chalcones; citric acidesters; chaste tree extract; clover extracts; coumestrol; CPC Peptide(available from Barnet Products); daidzein; dang gui extract;darutoside; debromo laurinterol; 1-decanoyl-glycero-phosphonic acid;dehydrocholesterol; dehydrodicreosol; dehydrodieugenol;dehydroepiandersterone; DERMOLECTINE (available from Sederma);dehydroascorbic acid; dehydroepiandersterone sulfate; dianethole;dihydroxy benzoic acid; 2,4 dihydroxybenzoic acid; diglycol guanidinesuccinate; diosgenin; disodium ascorbyl phosphate; dodecanedioic acid;Ederline (available from Seporga); Enderline (available fromLaboratories Seporga); equol; eriodictyol; estrogen and its derivatives;ETF (available from Laboratories Seporga); ethocyn; ELESERYL SH(available from Laboratories Serobiologiques, located in Somerville,N.J.); ENDONUCLEINE (available from Laboratories Serobiologiques);ergosterol; eythrobic acid; fennel extract; fenugreek seed extract;FIBRASTIL (available from Sederma); FIBROSTIMULINES S and P (availablefrom Sederma); FIRMOGEN LS 8445 (available from LaboratoriesSerobiologiques); formononetin; forsythia fruit extract; gallic acidesters; gamma amino butyric acid; GATULINE RC (available fromGattlefosse, located in Priest, France); genistein; genisteine; genisticacid; gentisyl alcohol; gingko bilboa extracts; ginseng extracts;ginsenoside; gluco pyranosyl-L-ascorbate; glutathione and its esters;glycitein; hesperitin; hexahydro curcumin; HMG—coenzyme A reductaseinhibitors; hops extracts; 11 hydroxy undecanoic acid; 10 hydroxydecanoic acid; 25-hydroxycholesterol; 7-hydroxylated sterols;hydroxyethyl isostearyloxy isopropanolamine; hydroxy-tetra methylpiperidinyloxy; hypotaurine; ibukijakou extract; isoflavone SG 10(available from Barnet Products); kinetin; kohki extract;L-2-OXO-thiazolidine-4-carboxylic acid esters; lactate dehydrogenaseinhibitors; 1-lauryl, -lyso-phosphatidyl choline; lectins; lichochalconeLF15 (available from Maruzen); licorice extracts; lignan; lumisterol;lupenes; luteolin; lysophosphitidic acid; magnesium ascorbyl phosphate;margin; melatonin; melibiose; metalloproteinase inhibitors; methoprene;methoprenic acid; mevalonic acid; MPC COMPLEX (available from CLR); Nmethyl serine; N methyl taurine; N, N.sup.1-bis(lactyl) cysteamine;naringenin; neotigogenin; o-desmethylangoiensin; oat beta glucan;oleanolic acid; pantethine; phenylalanine; photoanethone; piperdine;placental extracts; pratensein; pregnenolone; pregnenolone acetate;pregnenolone succinate; premarin; quillaic acid; raloxifene; REPAIRFACTOR 1 and REPAIR FACTOR FCP (both available from Sederna); retinoates(esters of C2-C20 alcohols); retinyl glucuronate; retinyl linoleate;S-carboxymethyl cysteine; SEANAMINE FP (available from LaboratoriesSerobiologiques); sodium ascorbyl phosphate; soya extracts; spleenextracts; tachysterol; taurine; tazarotene; tempol; thymulen; thymusextracts; thyroid hormones; tigogenin; tocopheryl retinoate; toxifolin;traumatic acid; tricholine citrate; trifoside; uracil derivatives;ursolic acid; vitamin D.sub.3 and its analogs; vitamin K; vitex extract;yam extract; yamogenin; zeatin; and mixtures thereof.

Skin Barrier Repair Actives:

Skin barrier repair actives are those skin care actives which can helprepair and replenish the natural moisture barrier function of theepidermis. Nonlimiting examples of skin barrier repair actives includeAlpha Lipid (available from Lucas Meyer); ascorbic acid; biotin; biotinesters; brassicasterol; caffeine; campesterol; canola derived sterols;Cennamides (available from Ennagram); Ceramax (available from AlbanMuller); CERAMAX (available from Quest, located in Ashford, England);CERAMIDE 2 and CERAMIDE HO3™ (both available from Sederma); CERAMIDE II(available from Quest); CERAMIDE III and IIIB (both available fromCosmoferm, located in Deft, Netherlands); CERAMIDE LS 3773 (availablefrom Laboratories Serobiologiques); CERAMINOL (available from Inocosm);Cerasol and Cephalip (both available from Pentapharm); cholesterol;cholesterol hydroxystearate; cholesterol isostearate; 7dehydrocholesterol; DERMATEIN BRC and DERMATEIN GSL (both available fromHormel); ELDEW CL 301 AND ELDEW PS 203 (both available from Ajinomoto);Fitobroside (available from Pentapharm); galactocerebrosides; Generol122 (available from Henkel); glyceryl serine amide; hydroxyethylisostearyl isopropanolamine; lactic acid; Lactomide (available fromPentapharm); lanolin; lanolin alcohols; lanosterol; lauric acid Nlaurylglucamide; lipoic acid; N-acetyl cysteine; N-acetyl-L-serine;N-methyl-L-Serine; Net Sterol-ISO (available from Barnet Products);vitamin B3 compounds (such as niacinamide and nicotinic acid); palmiticacid; panthenol; panthetine; phosphodiesterase inhibitors; PHYTO/CER(available from Intergen); phytoglycolipid millet extract (availablefrom Barnet Products Distributer, located in Englewood, N.J.);PHYTOSPHINGOSINE (available from Gist Brocades, located in King ofPrussia, Pa.); PSENDOFILAGGRIN (available from Brooks Industries,located in South Plainfield, N.J.); QUESTAMIDE H (available from Quest);serine; sigmasterol; sitosterol; soybean derived sterols; sphingosine;sphingomylinase; S-lactoyl glutathione; stearic acid; Structurine(available from Silah); SUPER STEROL ESTERS (available from Croda);thioctic acid; THSC CERAMIDE OIL (available from Campo Research);trimethyl glycine; tocopheryl nicotinate; vitamin D.sub.3; Y2 (availablefrom Ocean Pharmaceutical); and mixtures thereof.

Non-Steroidal Cosmetic Soothing Actives:

Cosmetic soothing actives can be effective in preventing or treatinginflammation of the skin. The soothing active enhances the skinappearance benefits of the present invention, e.g., such agentscontribute to a more uniform and acceptable skin tone or color. Theexact amount of anti-inflammatory agent to be used in the compositionswill depend on the particular anti-inflammatory agent utilized sincesuch agents vary widely in potency. Nonlimiting examples of cosmeticsoothing agents include the following categories: propionic acidderivatives; acetic acid derivatives; fenamic acid derivatives;biphenylcarboxylic acid derivatives; and oxicams. All of these cosmeticsoothing actives are fully described in U.S. Pat. No. 4,985,459 toSunshine et al., issued Jan. 15, 1991, incorporated by reference hereinin its entirety. Nonlimiting examples of useful cosmetic soothingactives include acetyl salicylic acid, ibuprofen, naproxen,benoxaprofen, flurbiprofen, fenoprofen, fenbufen, ketoprofen,indoprofen, pirprofen, carprofen, oxaprozin, pranoprofen, miroprofen,tioxaprofen, suprofen, alminoprofen, tiaprofenic acid, fluprofen,bucloxic acid, absinthium, acacia, aescin, alder buckthorn extract,allantoin, aloe, APT (available from Centerchem), arnica, astragalus,astragalus root extract, azulene, Baicalin SR 15 (available from BarnetProducts Dist.), baikal skullcap, baizhu, balsam canada, bee pollen,BIOPHYTEX (available from Laboratories Serobiologiques), bisabolol,black cohosh, black cohosh extract blue cohosh, blue cohosh extract,boneset, borage, borage oil, bradykinin antagonists, bromelain,calendula, calendula extract, Canadian Willowbark Extract (availablefrom Fytokem), candelilla wax, Cangzhu, canola phytosterols, capsicum,carboxypeptidase, celery seed, celery stem extract, CENTAURIUM(available from Sederma), centaury extract, chamazulene, chamomile,chamomile extract, chaparral, chaste tree, chaste tree extract,chickweed, chicory root, chicory root extract, chirata, chishao,collodial oatmeal, comfrey, comfrey extract, CROMOIST CM GLUCAN(available from Croda), darutoside, dehurian angelica, devil's claw,divalent metals (such as, magnesium, strontium, and manganese),doggrass, dogwood, Eashave (available from Pentapharm), eleuthero,ELHIBIN (available from Pentapharm), ENTELINE 2 (available from Secma),ephedra, epimedium, esculoside; ethacrynic acid, evening primrose,eyebright, Extract LE-100 (available from Sino Lion), Fangfeng,feverfew, ficin, forsythia fruit, Fytosterol 85 (available fromFytokem), ganoderma, gaoben, Gatuline A (available from Gattefosse),gentian, germanium extract, gingko bilboa extract, ginkgo, ginsengextract, goldenseal, gorgonian extract, gotu kola, grape fruit extract,guaiac wood oil, guggal extract, helenalin esters, henna, honeysuckleflower, horehound extract, horsechestnut, horsetail, huzhang, hypericum,ichthyol, immortelle, ipecac, job's tears, jujube, kola extract,LANACHRYS 28 (available from Lana Tech), lemon oil, lianqiao, licoriceroot, ligusticum, ligustrum, lovage root, luffa, mace, magnolia flower,manjistha extract, margaspidin, matricin, melatonin, MICROAT IRC(available from Nurture), mints, mistletoe, Modulene (available fromSeporga), mono or diglucosides of glabridin, mono or diglucosides ofgentisin, MTA (5′-deoxy-5′-methythioadenosine), mung bean extract, musk,N-methyl arginine, oat beta glucan, oat extract, orange, panthenol,papain, phenoxyacetic acid, peony bark, peony root, Phytoplenolin(available from Bio Botanica), phytosphingosine, Preregen (availablefrom Pentapharm), purslane, QUENCH T (available from Centerchem),quillaia, red sage, rehmannia, rhubarb, rosemary, rosmarinic acid, royaljelly, rue, rutin, sandlewood, sanqi, sarsaparilla, saw palmetto,SENSILINE (available from Silab), SIEGESBECKIA (available from Sederma),stearyl glycyrrhetinate, Stimutex (available from Pentapharm), storax,strontium nitrate, sweet birch oil, sweet woodruff, tagetes, teaextract, thyme extract, tienchi ginseng, tocopherol, tocopheryl acetate,triclosan, turmeric, urimei, ursolic acid, white pine bark, witch hazelxinyi, yarrow, yeast extract, yucca, and mixtures thereof.

Artificial Tanning Actives and Accelerators.

Artificial tanning actives can help in simulating a natural suntan byincreasing melanin in the skin or by producing the appearance ofincreased melanin in the skin. Nonlimiting examples of artificialtanning agents and accelerators include dihydroxyacetaone; tyrosine;tyrosine esters such as ethyl tyrosinate and glucose tyrosinate; acetyltyrosine; phospho-DOPA; brazilin; caffeine; coffee extracts;dihydroxyacetone; DNA fragments; isobutyl methyl xanthine; methylxanthine; Phototan (available from Laboratoires Serobiologiques);prostaglandins; tea extracts; theophylline; tyrosine; UNIPERTAN P2002and UNIPERTAN P27 (both available from Unichem); and mixtures thereof.

Skin Lightening Actives:

Skin lightening actives can actually decrease the amount of melanin inthe skin or provide such an effect by other mechanisms. Skin lighteningactives suitable for use herein are described in copending patentapplication Ser. No. 08/479,935, filed on Jun. 7, 1995 in the name ofHillebrand, corresponding to PCT Application No. U.S. Ser. No. 95/07432,filed Jun. 12, 1995; and copending patent application Ser. No.08/390,152, filed on Feb. 24, 1995 in the names of Kalla L. Kvalnes,Mitchell A. DeLong, Barton J. Bradbury, Curtis B. Motley, and John D.Carter, corresponding to PCT Application No. U.S. Ser. No. 95/02809,filed Mar. 1, 1995, published Sep. 8, 1995; all incorporated herein byreference. Nonlimiting examples of skin lightening actives useful hereininclude adapalene, aloe extract, alpha-glycaryl-L-ascorbic acid,aminotyroxine, ammonium lactate, anethole derivatives, apple extract,arbutin, areca catechu L. extract, ascorbic acid, ascorbyl palmitate,azelaic acid, bamboo extract, bearberry extract, bletilla tuber,bupleurum falcatum extract, burnet extract, Burnet Power (available fromBarnet Products), butyl hydroxy anisole, butyl hydroxy toluene, butylresoreinol, Chuanxiong, cola decaballo extract, Dang-Gui, deoxyarbutin,1,3 diphenyl propane derivatives, 2,5 dihydroxybenzoic acid and itsderivatives, 2-(4-acetoxyphenyl)-1,3 dithane, 2-(4-hydroxyphenyl)-1,3dithane, ellagic acid, escinol, estragole derivatives, esculoside,esculetin, FADEOUT (available from Pentapharm), Fangfeng, fennelextract, gallic acid and its derivatives, ganodenna extract, gaoben,GATULINE WHITENING (available from Gattlefosse), genistic acid and itsderivatives, gentisyl alcohol, glabridin and its derivatives, glucopyranosyl-1-ascorbate, gluconic acid, glucosamine, glycolic acid,glycyrrhizinic acid, green tea extract,4-Hydroxy-5-methyl-3[2H]-furanone, hydroquinine, 4 hydroxyanisole andits derivatives, 4-hydroxy benzoic acid derivatives, hydroxycaprylicacid, hyptis extract, inositol ascorbate, kojic acid, kojic dipalnitate,lactic acid, lemon extract, licorice extract, Licorice P-TH (availablefrom Barnet Products), linoleic acid, magnesium ascorbyl phosphate,Melfade (available from Pentapharm), MELAWHITE (available fromPentapharm), Melanostatine DM (available from Laboratories Seporga),morus alba extract, mulberry root extract, niacinamide, 5-octanoylsalicylic acid, parsley extract, phellinus linteus extract, pinon blancoextract, pinon negro extract, piri-piri extract, pyrogallol derivatives,retinoic acid, retinol, retinyl esters (acetate, propionate, palmitate,linoleate), 2,4 resorcinol derivatives, 3,5 resorcinol derivatives, rosefruit extract, rucinol, salicylic acid, Song-Yi extract, Sophora Powder(available from Barnet Products), 4-thioresorein, 3,4,5 trihydroxybenzylderivatives, tranexamic acid, tyrostat (Rumex Extract available fromFytokem), Tyroslat 10,11 (available from Fytokem), vanilla derivatives,vitamin D.sub.3 and its analogs, and mixtures thereof.

Sunscreen Actives:

Also useful herein are sunscreening actives. A wide variety ofsunscreening agents are described in U.S. Pat. No. 5,087,445, to Haffeyet al., issued Feb. 11, 1992; U.S. Pat. No. 5,073,372, to Turner et al.,issued Dec. 17, 1991; U.S. Pat. No. 5,073,371, to Turner et al. issuedDec. 17, 1991; and Segarin, et al., at Chapter VIII, pages 189 et seq.,of Cosmetics Science and Technology, all of which are incorporatedherein by reference in their entirety. Nonlimiting examples ofsunscreens which are useful in the compositions of the present inventionare those selected from the group consisting of 2-ethylhexylp-methoxycinnamate, 2-ethylhexyl N, N-dimethyl-p-aminobenzoate,p-aminobenzoic acid, 2-phenylbenzimidazole-5-sulfonic acid, octocrylene,oxybenzone, homomenthyl salicylate, octyl salicylate,4,4′-methoxy-t-butyldibenzoylmethane, 4-isopropyl dibenzoylmethane,3-benzylidene camphor, 3-(4-methylbenzylidene) camphor, titaniumdioxide, zinc oxide, silica, iron oxide, and mixtures thereof. Stillother useful sunscreens are those disclosed in U.S. Pat. No. 4,937,370,to Sabatelli, issued Jun. 26, 1990; and U.S. Pat. No. 4,999,186, toSabatelli et al., issued Mar. 12, 1991; these two references areincorporated by reference herein in their entirety. Still other usefulsunscreens include aminobenzoic acid (PABA), benzylidene camphor, butylmethoxy dibenzoyl methane, diethanolamine p-methoxycinnamate,dioxybenzone, ethyl dihydroxypropyl (PABA), glyceryl aminobenzoate,homomenthyl salicylate, isopropyl dibenzoyl methane, lawsone anddihydroxyacetone, menthyl anthranilate, methyl anthranilate, methylbenzylidene camphor, octocrylene, octyl dimethyl (PABA), octylmethoxycinnamate, oxybenzone, 2-phenylbenzimidazole-5-sulfonic acid, redpetrolatum, sulisobenzone, titanium dioxide, triethanolamine salicylate,zinc oxide, and mixtures thereof. Examples of these sunscreens includethose selected from the group consisting of4-N,N-(2-ethylhexyl)methylaminobenzoic acid ester of2,4-dihydroxybenzophenone, 4-N,N-(2-ethylhexyl)methylaminobenzoic acidester with 4-hydroxydibenzoylmethane,4-N,N-(2-ethylhexyl)-methylaminobenzoic acid ester of2-hydroxy-4-(2-hydroxyethoxy)benzophenone,4-N,N-(2-ethylhexyl)-methylaminobenzoic acid ester of4-(2-hydroxyethoxy)dibenzoylmethane, and mixtures thereof.

Exact amounts of sunscreens which can be employed will vary dependingupon the sunscreen chosen and the desired Sun Protection Factor (SPF) tobe achieved. SPF is a commonly used measure of photoprotection of asunscreen against erythema. See Federal Register, Vol. 43, No. 166, pp.38206-38269, Aug. 25, 1978, which is incorporated herein by reference inits entirety.

Skin Tightening Agents:

Also useful as active ingredients in the present invention are skintightening agents. Nonlimiting examples of skin tightening agents whichare useful in the compositions of the present invention are thoseselected from the group consisting of Biocare SA (available fromAmerchol); egg albumen; Flexan 130 (available from National Starch);Gatuline Lifting (available from Gattefosse); Pentacare HP (availablefrom Pentapharm); Vegeseryl (available from Laboratories Serobioloques)and mixtures thereof.

Anti-Itch Ingredients:

Also useful as active ingredients in the present invention are anti-itchingredients. Nonlimiting examples of anti-itch ingredients which areuseful in the compositions of the present invention are those selectedfrom the group consisting of Stimu-tex (available from Pentapharm);Takanal (available from Ikeda-Distributer); Ichthyol (available fromInternational Sourcing-Distributor); Oxygenated Glyceryl Triesters(available from Seporgia) and mixtures thereof.

Hair Growth Inhibitors:

Nonlimiting examples of hair growth inhibitors which are useful in thecompositions of the present invention include 17-beta estradiol,adamantyguanidines, adamantylamidines, adenylosuccinate synthaseinhibitors, anti angiogenic steroids, aspartate transcarbamylaseinhibitors, betamethasone valerate, bisabolol, copper ions, curcumaextract, cycloxygenase inhibitors, cysteme pathway inhibitors,dehydroacetic acid, dehydroepiandrosterone, diopyros leak extract,epidermal growth factor, epigallocatechin, essential fatty acids,evening primrose oil, gamma glutamyl transpeptidase inhibitors, gingeroil, glucose metabolism inhibitors, glutamine metabolism inhibitors,glutathione, green tea extracts, heparin, Kapilanne (available fromInternational Sourcing Distributor), L, 5 diaminopentanoic acid,L-aspargine synthase inhibitors, linoleic acid, lipoxygenase inhibitors,longa extract, mimosinamine dihydrochloride, mimosine, nitric oxidesynthase inhibitors, non-steroidal antiinflamatories, ornithinedecarboxylase inhibitors, omthine aminotransferase inhibitors,panthenol, phorhetur, phosphodiesterase inhibitors, pleione extract,protein kinase C inhibitors, salpha reductase inhibitors, sulfhydralreactive compounds, tioxolone, transforming growth factor beta 1, urea,zinc ions and mixtures thereof.

Desquamating Enzyme Enhancers:

Nonlimiting examples of desquamating enzyme enhancers which are usefulin the compositions of the present invention include alanine, aspasticacid, N methyl serine, serine, trimethyl glycine and mixtures thereof.

Anti-Glycation Agents:

A nonlimiting example of an anti-glycation agent which is useful in thecompositions of the present invention would be Amadorine (available fromBarnet Products Distributor).

Other useful actives include skin bleaching (or lightening) activesincluding but not limited to hydroquinone, ascorbic acid, kojic acid andsodium metabisulfite.

Other useful actives include antiperspirant actives. Suitable for useherein are those which comprise any compound, composition or mixturethereof having antiperspirant activity. Astringent metallic salts areantiperspirant materials for use herein, for example, the inorganic andorganic salts of aluminum, zirconium and zinc, as well as mixturesthereof. Non-limiting examples are the aluminum and zirconium salts,such as aluminum halides, aluminum hydroxy halides, zirconyl oxidehalides, zirconyl hydroxy halides, and mixtures thereof.

Additionally, deodorant actives in the form of bacteriostats may beincorporated into the present compositions. Suitable deodorantbacteriostats include 2,2′-methylenebis(3,4,6-trichlorophenol),2,4,4′-trichloro-2′-hydroxy(diphenyl ether), zinc phenolsulfonate,2,2′-thiobis(4,6-dichlorophenol), p-chloro-m-xylenol, dichloro-m-xylenoland the like. One example is 2,4,4′-trichloro-2′-hydroxy(diphenylether), which is generically known as triclosan and available from theCiba-Geigy Corporation under the trademark, Irgasan DP-300 Registered™.When triclosan is utilized it will be present in a range from about 0.05to about 0.9%, for example, from about 0.1 to about 0.5% (weight %) ofthe composition. Other types of bacteriostats include sodium N-lauroylsarcosine, sodium N-palmitoyl sarcosine, lauroyl sarcosine, N-myristoylglycine, potassium N-lauroyl sarcosine and aluminum chlorhydroxy lactate(sold by Reheis Chemical Company under trademark of Chloracel).

Based on a weight percentage, the active component may be present in acomposition in a range of about 0.0001% to about 60.0%, for example,about 0.005% to about 50% (weight %). In one embodiment, methylsalicylate, menthol, camphor and capsaicin are each present in acomposition in a range of about 0.0001% to about 60%. For example,methyl salicylate may be present in a range of about 0.1% to about 40.0%(weight percentage), for example, about 0.5% to about 30%; menthol maybe present in a range of about 0.1% to about 20%, for example, about0.5% to about 16%; camphor may be present in range of about 0.1% toabout 20%, for example, about 0.5% to about 6%; and capsaicin may bepresent in a range of about 0.0001% to about 5.0% weight percentage, forexample, about 0.002% to about 0.01%.

Some or all of the substances (e.g., analgesic active(s)) which may beincluded in a composition may be dissolved in a silicone material. Inone embodiment, some or all of the substances (e.g., analgesicactive(s)) which are included in a composition are dissolved in one ormore low molecular weight silicones. In another embodiment, one or moreof the substances (e.g., analgesic active(s)) which are included in acomposition are dissolved in an organic solvent and then added to thesilicone material. For example, capsaicin may be dissolved in a C12-C15alkyl benzoate and then added to the silicone material which comprises acomposition. In weight percent, about 3% to about 15% (weight % ofcomposition), for example, about 7% to about 15% of alkyl benzoate canbe used to dissolve capsaicin.

Organic compounds useful in the present composition include, withoutlimitation, inert aromatic hydrocarbons, aliphatic hydrocarbons,alcohols, aldehydes, ketones, esters, ethers, glycols, glycol ethers,alkyl halides, or aromatic halides. Representative of some commonorganic solvents are alcohols such as methanol, ethanol, 1-propanol,cyclohexanol, benzyl alcohol, 2-octanol, ethylene glycol, propyleneglycol, and glycerol; aliphatic hydrocarbons such as pentane,cyclohexane, heptane, VM&P solvent, isoparaffinic solvents and mineralspirits; alkyl halides such as chloroform, carbon tetrachloride,perchloroethylene, ethylchloride and chlorbbenzene; aromatichydrocarbons such as benzene, toluene, ethybenzene and xylene; esterssuch as ethyl acetate, isopropyl acetate, ethyl acetoacetate, amylacetate, isobutyl isobutyrate, and benzyl acetate; ethers such as ethylether, n-butyl ether, tetrahydrofuran, and 1,4-dioxane; glycol etherssuch as ethylene glycol monomethyl ether, ethylene glycol monomethylether acetate, diethylene glycol monobutyl ether and propylene glycolmonophenyl ether; ketones such as acetone, methyl ethyl ketone,cyclohexanone, diacetone alcohol, methyl amyl ketone, and diisobutylketone.

Low molecular weight silicones useful in the present invention includevolatile silicones. By volatile silicone it is meant a silicone materialthat has a measurable vapor pressure at ambient temperature, forexample, silicones with a boiling point of about 250 degrees C. or lessat about atmospheric pressure and with viscosities generally less thanabout 10 centistokes (CS) measured at twenty-five degrees C., forexample, 0.65 to 5.0 centistokes.

Low molecular weight cyclic silicones such as cyclomethicones, forexample, octylmethylcyclotetrasiloxane, hexamethylcyclotrisiloxane anddecamethylcyclopentasiloxane and the like are contemplated for use inthe present compositions. Low molecular weight linear silicones may alsobe useful, for example, polydimethylsiloxanes. Particularly useful lowmolecular weight silicones include hexamethyldisiloxane and lowmolecular weight dimethicone. Mixtures of these and other low molecularweight silicones are also within the scope of the invention.

The compositions may include low molecular weight silicone in a range ofabout 5% to about 95% (weight %), for example, about 30% to about 80%.In one embodiment, the compositions include about 35% to about 75%hexamethyldisiloxane and/or low molecular weight dimethicones.

Low molecular weight silicones including hexamethyldisiloxane and lowmolecular weight dimethicones are clear fluids, and are essentiallyodorless, nontoxic, nongreasy and nonstinging. These fluids arenonirritating to skin, and exhibit enhanced spreadability and ease ofapplication to the skin.

Without wishing to limit the invention to any theory or mechanism ofoperation it is believed that after application of a presentcomposition, the low molecular weight silicones substantially evaporateleaving behind some or all of the remainder of the composition which mayinclude a high molecular weight silicone material. This high molecularweight silicone may have an average molecular weight in excess of100,000 (e.g., between about 500,000 and about 5,000,000) and/or benon-volatile.

Examples of silicone polymers contemplated for use in the presentcompositions include, without limitation, copolymers such as stearylmethyl-dimethyl siloxane copolymer (Gransil SR-CYC, available from GrantIndustries, Elmwood Park, N.J.); Polysilicone-11 (i.e., a crosslinkedsilicone rubber formed by the reaction of vinyl terminated silicone andmethylhydrodimethyl siloxane in the presence of cyclomethicone),cetearyl dimethicone/vinyl dimethicone crosspolymer (i.e., a copolymerof cetearyl dimethicone crosslinked with vinyl dimethyl polysiloxane),dimethicone/phenyl vinyl dimethicone crosspolymer (i.e., copolymer ofdimethylpolysiloxane crosslinked with phenyl vinyl dimethylsiloxane),and dimethicone/vinyl dimethicone crosspolymer (i.e., copolymer ofdimethylpolysiloxane crosslinked with vinyl dimethylsiloxane).Particularly useful high molecular weight silicones include crosslinkedsiloxane, for example dimethicone crosspolymers or dimethiconederivative crosspolymers and silicone gums, for example, dimethiconeelastomer gum.

In one particularly useful aspect of the present invention, theconsistency of a composition is controlled by adding certain amounts ofhigh molecular weight silicone polymers to the low molecular weightsilicones. The viscosity range of the final compositions may be adjustedto about 0.1 CS to about 50,000 CS or about 10,000,000, for example,about 0.1 CS to about 3500 CS or about 0.5 CS to about 50 CS. One usefulviscosity range for the present compositions may be about 0.65 CS toabout 10 CS.

In one particularly useful embodiment, a dimethicone crosspolymer isemployed in a composition and is effective to control the consistency ofcompositions. In another particularly useful embodiment, dimethicone gumis employed in a composition and is effective to control the consistencyof compositions. In another particularly useful embodiment, dimethiconecrosspolymers and/or dimethicone gum are employed in a composition andare effective to control the consistency of compositions. The viscosityof the crosspolymer employed may be about 1,000,000 or higher.

Advantageously, dimethicone crosspolymers and dimethicone gum do nothave a greasy feel. In addition, these compositions can provide a waterresistant or water proof film when applied to a surface, for example,when applied to the skin. This water resistance or water proofing canprevent an undesired removal of actives upon exposure to moisture. Thefilm can also provide for moisture retention. The moisture retention maybe effective to retain actives, for example, volatile actives, inproximity to the surface to which the composition is applied, forexample, the skin.

The range of molecular weight of high molecular weight silicones, forexample, dimethicone crosspolymers and dimethicone gum may be from about100,000 to about 100,000,000, for example, about 500,000 to about50,000,000 or about 1,000,000 to about 10,000,000.

The high molecular weight silicones, for example, dimethiconecrosspolymers and dimethicone gum may be capped. Caps may be anysuitable group including methyl groups, phenyl groups, hydroxy groups,vinyls and/or amino groups or mixtures or combinations thereof.

The compositions may include high molecular weight silicone in a rangeof about 5% to about 95% (weight %), for example, about 3% to about 30%.For example, a composition may include dimethicone crosspolymer and ordimethicone gum in a range of about 5% to about 25%.

A silicone component includes the silicone material which comprises acomposition of the invention. In one broad embodiment, a composition ofthe invention includes a silicone component, which includes lowmolecular weight silicones and high molecular weight silicones presentat a concentration in a range of between about 30% to about 99.999%(weight %), for example, about 40-99.9%.

In one embodiment, one or more of substances (e.g., analgesic active(s))which are included in a composition of the invention are dissolved intothe silicone component.

In certain embodiments, the present compositions can include additionalsubstances including, without limitation, moisturizers, emollients,fragrances preservatives and sugars.

The compositions of the present invention can include one or moremoisturizing materials. These materials include, but are not limited to,urea; guanidine; glycolic acid and glycolate salts (e.g. ammonium andquaternary alkyl ammonium); lactic acid and lactate salts (e.g. ammoniumand quaternary alkyl ammonium); aloe vera in any of its variety of forms(e.g., aloe vera gel); polyhydroxy alcohols such as sorbitol, glycerol,hexanetriol, propylene glycol, butylene glycol, hexylene glycol and thelike; polyethylene glycols; sugars and starches; sugar and starchderivatives (e.g., alkoxylated glucose); hyaluronic acid; lactamidemonoethanolamine; acetamide monoethanolamine: and mixtures thereof.

The compositions useful the present invention may also include one ormore emollients. Examples of suitable emollients which may be useful inthe present compositions include, but are not limited to, highlybranched hydrocarbons, and non-polar carboxylic acid and alcohol esters,and mixtures thereof. Some emollients that may be useful in the presentcompositions are further described in U.S. Pat. No. 4,919,934, which isincorporated herein by reference in its entirety.

Examples of fragrances which may be useful in the present compositionsinclude, without limitation, peppermint, rose oil, rose water, aloevera, clove oil, eucalyptus oil, and other plant extracts. Certainfragrances may require a solubilizer, e.g., PPG-5-ceteareth-20. Toeliminate certain odors from compositions, masking agents may be used.An example of a masking agent includes ethylene brassylate. Otherfragrances and masking agents are listed on pages 1639-40 of the ICTHandbook.

Preservatives can be used to protect the compositions from degradation.Examples of preservatives which may be useful in the presentcompositions include, without limitation, liquipar oil, phenoxyethanol,methyl paraben, propyl paraben, butyl paraben, isopropyl paraben,isobutyl paraben, dieizolidinyl urea, imidazolidinyl urea, diazolindylurea, benzalkonium chloride, benzethonium chloride, phenol, and mixturesthereof (e.g., liquipar oil). Other preservatives are listed on pages1654-55 of the ICT Handbook.

Examples of sugars which may be useful in the present compositionsinclude, without limitation, monosaccharides, disaccharides, andpolysccharides such as glucose, xylose, fructose, reose, ribose,pentose, arabinose, allose, tallose, altrose, mannose, galactose,lactose, sucrose, erythrose, or any combination thereof.

The compositions of the present invention are used in conventional waysto provide a desired benefit. The present compositions can be used toprovide, for example, pain relief (analgesic) by, for example, topicalapplication to the skin. Methods of use depend upon the type ofcomposition employed but, in one broad embodiment, involve applicationof an effective amount of the product to the skin which may then beallowed to remain on the skin. By “effective amount” is meant an amountsufficient to provide a benefit desired. For example, an effectiveamount of a composition is applied to and rubbed onto the skin.

Compositions of the invention may be substantially anhydrous allowingfor application to the skin with no greasy feel. The compositions dryrapidly leaving behind a silicone polymer film with no oily residue thatprevents evaporation or washing away of actives thereby retaining theactive component in proximity to the surface of the skin to which thecomposition is applied.

The following non-limiting examples illustrate certain aspects of thepresent invention.

EXAMPLES

Percentages presented in the examples are weight percentages. A weightpercentage is a percentage expressed as the percentage of the totalcomposition based on weight.

Example 1

Methyl salicylate 30.0%

Menthol 10.0%

Camphor 4.0%

Low molecular weight dimethicone 45.0%

Dimethicone crosspolymer 11.0%

The methyl salicylate, menthol and camphor are dissolved in the lowmolecular weight dimethicone producing an admixture and the dimethiconecrosspolymer is blended into the admixture.

Example 2

Methyl salicylate 15.0%

Menthol 7.5%

Camphor 2.5%

Hexamethyldisiloxane 61.0%

Dimethicone crosspolymer 14.0%

The methyl salicylate, camphor and/or menthol are dissolved in thehexamethyldisiloxane producing an admixture and the dimethiconecrosspolymer is blended into the admixture.

Example 3

Methyl salicylate 5.0%

Menthol 1.0%

Camphor 2.0%

Capsaicin 0.075%

C12-C15 alkyl benzoate 16.925%

Hexamethyldisiloxane 61.0%

Dimethicone crosspolymer 14.0%

The capsaicin is dissolved in the alkyl benzoate and the methylsalicylate, menthol and camphor are dissolved in thehexamethyldisiloxane to which the capsaicin/alkyl benzoate solution isadded producing an admixture. The dimethicone crosspolymer is blendedinto the admixture.

Example 4

Capsaican 0.1%

C12-C15 alkyl benzoate 15.9%

Low molecular weight dimethicone 70.0%

Dimethicone crosspolymer 14.0%

The capsaicin is dissolved in the alkyl benzoate. The capsaicin/alkylbenzoate solution and the methyl salicylate, menthol and camphor areadded to the low molecular weight dimethicone producing an admixture andthe dimethicone crosspolymer is blended into the admixture.

Example 5

Methyl salicylate 30.0%

Menthol 10.0%

Camphor 4.0%

Low molecular weight dimethicone 45.0%

Dimethicone elastomer gum 11.0%

The methyl salicylate, menthol and camphor are dissolved in the lowmolecular weight dimethicone producing an admixture and the dimethiconeelastomer gum is blended into the admixture.

Example 6

Methyl salicylate 15.0%

Menthol 7.5%

Camphor 2.5%

Hexamethyldisiloxane 61.0%

Dimethicone elastomer gum 14.0%

The methyl salicylate, menthol and camphor are dissolved in thehexamethyldisiloxane producing an admixture and the dimethiconeelastomer gum is blended into the admixture.

Example 7

Methyl salicylate 5.0%

Menthol 1.0%

Camphor 2.0%

Capsaicin 0.075%

C12-C15 alkyl benzoate 16.925%

Hexamethyldisiloxane 61.0%

Dimethicone elastomer gum 14.0%

The capsaicin is dissolved in the alkyl benzoate and the methylsalicylate, menthol and camphor are dissolved in thehexamethyldisiloxane to which the capsaicin/alkyl benzoate solution isadded producing an admixture. The dimethicone elastomer gum is blendedinto the admixture.

Example 8

Capsaican 0.1%

C12-C15 alkyl benzoate 15.9%

Low molecular weight dimethicone 70.0%

Dimethicone elastomer gum 14.0%

The capsaicin is dissolved in the alkyl benzoate which is then added tothe low molecular weight dimethicone producing an admixture. Thedimethicone elastomer gum is blended into the admixture.

Example 9

Methyl salicylate 30.0%

Menthol 10.0%

Camphor 4.0%

Low molecular weight dimethicone 45.0%

Dimethicone crosspolymer 6.0%

Dimethicone elastomer gum 5.0%

The methyl salicylate, menthol and camphor are dissolved in the lowmolecular weight dimethicone producing an admixture and the dimethiconeelastomer gum and dimethicone crosspolymer are blended into theadmixture.

Example 10

Methyl salicylate 15.0%

Menthol 7.5%

Camphor 2.5%

Hexamethyldisiloxane 61.0%

Dimethicone crosspolymer 7.0%

Dimethicone elastomer gum 7.0%

The methyl salicylate, menthol and camphor are dissolved in thehexamethyldisiloxane producing an admixture and the dimethiconeelastomer gum and dimethicone crosspolymer are blended into theadmixture.

Example 11

Methyl salicylate 5.0%

Menthol 1.0%

Camphor 2.0%

Capsaicin 0.075%

C12-C15 alkyl benzoate 16.925%

Hexamethyldisiloxane 61.0%

Dimethicone crosspolymer 7.0%

Dimethicone elastomer gum 7.0%

The capsaicin is dissolved in the alkyl benzoate and the methylsalicylate, menthol and camphor are dissolved in thehexamethyldisiloxane to which the capsaicin/alkyl benzoate solution isadded producing an admixture. The Dimethicone crosspolymer anddimethicone elastomer gum are blended into the admixture.

Example 12

Capsaican 0.1%

C12-C15 alkyl benzoate 15.9%

Low molecular weight dimethicone 70.0%

Dimethicone crosspolymer 7.0%

Dimethicone elastomer gum 7.0%

The capsaicin is dissolved in the alkyl benzoate and is added to the lowmolecular weight dimethicone producing an admixture. The dimethiconecrosspolymer and dimethicone elastomer gum are blended into theadmixture.

Example 13

Retinol-15D (a 15% solution of all trans 0.3%

retinol in caprylic/capric triglyceride,

stabilized with 1% BHT)

Low molecular weight dimethicone 80.0%

Dimethicone crosspolymer 19.7%

The Retinol-15D is dissolved in the low molecular weight dimethicone,producing an admixture, and the dimethicone crosspolymer is blended intothe admixture using the cold mix process. The resulting composition ispackaged in opaque high density polyethylene (HDPE) containers duringthe production processing and packaging. No inert gas is used. Thecompositions in these containers are tested and found to have no retinoldegradation.

The containers are resealed and are then exposed to sunlight andprobable higher than normal (room) temperatures, and retested afterthree months. After three months of such exposure, the compositions inthe opaque containers are found to be optically clear, and to containactive retinol.

Similar tests are conducted except that the compositions are placed inclear polyethylene terephthalate (PET) containers and clear glasscontainers. Again, no inert gas is used during packaging. Uponretesting, after three months of exposure to sunlight and higher thannormal temperatures, the compositions in the PET and glass containersare hazy and contain no active retinol.

Example 14

Retinol 15D (a 15% solution of all trans 0.3%

retinol in caprylic/capric triglyceride,

stabilized with 1% BHT)

Low molecular weight dimethicone 80.0%

Dimethicone gum 19.7%

The Retinol-15D is dissolved in the low molecular weight dimethicone,producing an admixture, and the dimethicone gum is blended into theadmixture using the cold mix process. The resulting composition ispackaged in opaque high density polyethylene (HDPE) containers under thesame conditions as Example 13. After testing, the compositions in thesecontainers are found to have no retinol degradation.

The containers are resealed and are then exposed to sunlight andprobable higher than normal (room) temperatures, and retested afterthree months. After three months of such exposure, the compositions inthe opaque containers are found to be optically clear, and to containactive retinol.

Similar tests are conducted except that the compositions are placed inclear polyethylene terephthalate (PET) containers and clear glasscontainers. Again, no inert gas is used during packaging. Uponretesting, after three months of exposure to sunlight and higher thannormal temperatures, the compositions in the PET and glass containersare hazy and contain no active retinol.

These tests, as set forth in Exhibits 13 and 14, show that the presentcompositions, prepared by the cold mix process without the use of inertgases, are stable when exposed to oxygen and higher than normaltemperatures, but unstable when exposed to light. Accordingly, suchcompositions preferably are to be packaged in opaque containers.

A number of publications, patents, and patent applications have beencited hereinabove. Each of the cited publications, patents, and patentapplications are hereby incorporated by reference in their entireties.

While this invention has been described with respect to various specificexamples and embodiments, it is to be understood that the invention isnot limited thereto and that it can be variously practiced with thescope of the following claims.

What is claimed is:
 1. An anhydrous composition comprising a highmolecular weight silicone component having a molecular weight between100,000 and about 100,000,000 daltons and a low molecular weightsilicone component, said low molecular weight silicone componentconsisting essentially of a low molecular weight linear siliconecomponent, and wherein said composition further comprises a soluble orsolubilized active component selected from the group consisting ofretinoic acid, retinoic acid derivatives, retinal, retinol, retinylesters and mixtures thereof; wherein the active component has increasedstability when the composition is stored in a container for three monthsrelative to the stability of the active component in an otherwiseidentical composition in which a cyclic low molecular weight siliconecomponent is substituted for the low molecular weight linear siliconecomponent and is stored in an identical container for the same period oftime.
 2. The composition of claim 1 wherein the active component hasincreased stability when the composition is exposed to higher than roomtemperature.
 3. The composition of claim 1 wherein the high molecularweight silicone component is a dimethicone gum is capped with one ormore groups selected from the class consisting of methyl groups,hydroxyl groups, phenyl groups, vinyls, amino groups and mixturesthereof.
 4. The composition of claim 1 wherein the low molecular weightsilicone is selected from the class consisting of low molecular weightdimethicones.
 5. The composition of claim 1 wherein the low molecularweight silicone comprises hexadimethylsiloxane.
 6. The composition ofclaim 1 wherein the active component is selected from the groupconsisting of retinoic acid, retinol, and mixtures thereof.
 7. Thecomposition of claim 1 wherein the active component comprises retinol.8. The composition of claim 1 wherein the active component comprisesabout 0.001% to about 10% by weight of the composition.
 9. Thecomposition of claim 1, wherein the anhydrous composition is disposedwithin an opaque package.
 10. The composition of claim 1, wherein theactive component comprises about 0.01% to about 0.5% by weight of theanhydrous composition.
 11. An anhydrous composition comprising a highmolecular weight dimethicone gum component having a molecular weightbetween 100,000 and about 100,000,000 daltons, a low molecular weightsilicone component consisting essentially of a low molecular weightlinear silicone component, and a soluble active component selected fromthe group consisting of retinoic acid, retinoic acid derivatives,retinal, retinol, retinyl esters, and mixtures thereof, wherein theactive component has increased stability when the composition is storedfor at least 30 days and exposed to oxygen, light, and/or roomtemperature relative to the stability of the same active component in anotherwise identical composition in which a cyclic low molecular weightsilicone component is substituted for the low molecular weight linearsilicone component and is stored for the same period of time and underthe same conditions.
 12. The composition of claim 11 wherein the lowmolecular weight silicone is selected from the class consisting of lowmolecular weight dimethicones.
 13. The composition of claim 11 whichfurther comprises hexadimethylsiloxane.
 14. The composition of claim 11wherein the active component is selected from the group consisting ofretinoic acid, retinol and mixtures thereof.
 15. The composition ofclaim 11 wherein the active component is retinol.
 16. The composition ofclaim 11 wherein the active component comprises about 0.0001% to about10% by weight of the composition.
 17. An anhydrous compositioncomprising a dimethicone gum component having a molecular weight between100,000 and about 100,000,000 daltons, a low molecular siliconecomponent consisting essentially of a low molecular weight lineardimethicone having a measurable vapor pressure at 25° C., and a solubleor solubilized active component selected from the group consisting ofretinoic acid, retinoic acid derivatives, retinal, retinol, retinylesters and mixtures thereof; the dimethicone gum and the low molecularweight dimethicone being present in the composition in an amount in arange of about 40-99.9% by weight, the active component having increasedstability when the composition is placed into a clear container andexposed to sunlight for about three months relative to the stability ofthe active component in an otherwise identical composition in which thelow molecular weight component is a cyclic siloxane stored underidentical conditions for an identical period of time.
 18. Thecomposition of claim 17, wherein the active component is selected fromthe group consisting of retinoic acid, retinol and mixtures thereof, andis present in an amount of about 0.0001% to about 10% by weight of thecomposition.
 19. The composition of claim 17, wherein the activecomponent is retinol.
 20. An anhydrous composition comprising adimethicone gum component having a molecular weight between 100,000 andabout 100,000,000 daltons; a low molecular weight silicone componentconsisting essentially of a linear dimethicone having a measurable vaporpressure at 25° C.; and a soluble or solubilized active componentselected from the group consisting of retinoic acid, retinoic acidderivatives, retinal, retinol, retinyl esters and mixtures thereof. 21.The composition of claim 20 wherein said low molecular weight lineardimethicone is selected from the group consisting of a dimethicone andhexamethyldisiloxane.